CEPV vs LCTX
Comparison between Cantor Equity Partners V Inc - Class A (CEPV, Company) and Lineage Cell Therapeutics Inc (LCTX, Company).
CEPV is from the Financial Services sector, while LCTX is from the Healthcare sector.
CEPV vs LCTX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CEPV vs LCTX - Historical Returns
Returns include dividend reinvestment.
CEPV vs LCTX - Annual Returns (1999 - 2026)
Returns include dividend reinvestment.
| Year | CEPV | LCTX |
|---|---|---|
| 2026 | +0.19% | -26.52% |
| 2025 | -0.49% | +224.27% |
| 2024 | N/A | -53.90% |
| 2023 | N/A | -11.38% |
| 2022 | N/A | -52.82% |
| 2021 | N/A | +26.94% |
| 2020 | N/A | +102.30% |
| 2019 | N/A | -14.42% |
| 2018 | N/A | -54.43% |
| 2017 | N/A | -40.93% |
| 2016 | N/A | -1.90% |
| 2015 | N/A | +4.06% |
| 2014 | N/A | +2.47% |
| 2013 | N/A | +8.76% |
| 2012 | N/A | -48.69% |
| 2011 | N/A | -34.87% |
| 2010 | N/A | +76.11% |
| 2009 | N/A | +141.72% |
| 2008 | N/A | +365.80% |
| 2007 | N/A | +57.72% |
| 2006 | N/A | -17.19% |
| 2005 | N/A | -79.47% |
| 2004 | N/A | +4.86% |
| 2003 | N/A | -15.34% |
| 2002 | N/A | -66.52% |
| 2001 | N/A | -42.50% |
| 2000 | N/A | -16.67% |
| 1999 | N/A | +3.64% |
CEPV vs LCTX Drawdown Comparison
The maximum drawdown for CEPV was -2.61%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The maximum drawdown for LCTX was -98.99%, occurring on Aug 28, 2006. This drawdown has not yet recovered.
The current CEPV drawdown is -0.48%. The current LCTX drawdown is -91.00%.
| Rank | CEPV | LCTX |
|---|---|---|
| #1 | -2.61% Jan 15, 2026 - Mar 27, 2026 | -98.99% Feb 24, 2000 - Aug 28, 2006 |
| #2 | -1.45% Nov 5, 2025 - Jan 15, 2026 | -30.10% Nov 8, 1999 - Jan 26, 2000 |
| #3 | N/A | -15.38% Jan 26, 2000 - Feb 18, 2000 |
| #4 | N/A | -3.66% Nov 1, 1999 - Nov 3, 1999 |
Correlation
Correlation between CEPV and LCTX is -0.60 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks